Locations:
Heavily pretreated patients experience improved progression-free survival and quality of life with CD20xCD3 therapy
Best practices for supporting patients with honesty and compassion
Goal-of-care discussions drive earlier hospice access
Combination therapy improves outcomes, but lobular patients still do worse overall than ductal counterparts
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Early results show strong clinical benefit rates
Standard of care is linked to better outcomes, but disease recurrence and other risk factors often drive alternative approaches
Multidisciplinary teams bring pathological and clinical expertise
Genetic variants exist irrespective of family history or other contributing factors
Large retrospective study suggests DOACs are safe, effective alternative to low-molecular-weight heparin in complex patient population
National Blood Clot Alliance collaborates with faith-based organizations on first-of-its-kind church bus tour
Advertisement
Advertisement
Search